Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Hair antiretroviral concentration is affected by hair type, segment position, housing, drug use, sexual behavior, kidney function, and genetics.

A woman's chronic headaches and hair loss were cured by treating her syphilis.

Five FDA-approved drugs may help block COVID-19 virus entry.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Six existing drugs may help block virus entry in COVID-19.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Five FDA-approved drugs may help block COVID-19 virus entry.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Entospletinib effectively prevents eye and skin GVHD in mice.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Researchers found several compounds that could potentially treat Zika virus.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

34% of patients on hepatitis C treatment had reversible skin issues.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.